PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 1158898-18 1975 These observations, particularly those made in the course of characterizine P"2, have led to the conclusion that cleavage of the peptide bond connecting the TA and TB portions of the prothrombin molecule (or its derivatives) produces a serine active center and, hence, a molecule possessing thrombin activity. Terbium 164-166 coagulation factor II, thrombin Homo sapiens 183-194 1158898-18 1975 These observations, particularly those made in the course of characterizine P"2, have led to the conclusion that cleavage of the peptide bond connecting the TA and TB portions of the prothrombin molecule (or its derivatives) produces a serine active center and, hence, a molecule possessing thrombin activity. Terbium 164-166 coagulation factor II, thrombin Homo sapiens 186-194 23074705-0 2012 A sensitive strategy for label-free and time-resolved fluorescence assay of thrombin using Tb-complex and unmodified gold nanoparticles. Terbium 91-93 coagulation factor II, thrombin Homo sapiens 76-84 23074705-4 2012 The fluorescence intensity of Tb-complexes increases as the concentration of thrombin increases. Terbium 30-32 coagulation factor II, thrombin Homo sapiens 77-85 23074705-5 2012 Due to the highly specific recognition ability of the aptamer for thrombin and the strong quenching property of GNPs for Tb-complexes, the proposed protocol has good selectivity and high sensitivity for thrombin. Terbium 121-123 coagulation factor II, thrombin Homo sapiens 66-74 23074705-5 2012 Due to the highly specific recognition ability of the aptamer for thrombin and the strong quenching property of GNPs for Tb-complexes, the proposed protocol has good selectivity and high sensitivity for thrombin. Terbium 121-123 coagulation factor II, thrombin Homo sapiens 203-211 22939121-5 2012 In the presence of target thrombin (TB), the TBA on the multilayer could catch the thrombin onto the electrode surface, which resulted in a barrier for electro-transfer, leading to the decrease of the electrochemical signal of Tb-Gra nanocomposites. Terbium 227-229 coagulation factor II, thrombin Homo sapiens 26-34 22939121-5 2012 In the presence of target thrombin (TB), the TBA on the multilayer could catch the thrombin onto the electrode surface, which resulted in a barrier for electro-transfer, leading to the decrease of the electrochemical signal of Tb-Gra nanocomposites. Terbium 227-229 coagulation factor II, thrombin Homo sapiens 36-38 22939121-5 2012 In the presence of target thrombin (TB), the TBA on the multilayer could catch the thrombin onto the electrode surface, which resulted in a barrier for electro-transfer, leading to the decrease of the electrochemical signal of Tb-Gra nanocomposites. Terbium 227-229 coagulation factor II, thrombin Homo sapiens 83-91 22540161-5 2012 RESULTS: In spiked samples, TB-402 inhibited FVIII:C by 30%, prolonged APTT by 4.5 s, and reduced the peak height in the thrombin generation assay to 56% +- 13% of the control value. Terbium 28-30 coagulation factor II, thrombin Homo sapiens 121-129 16104640-6 2005 However, the sensitivity of detection of TB in the presence of HIV increased to 87% by concomitant detection of circulating free and CIC serine protease antigen. Terbium 41-43 coagulation factor II, thrombin Homo sapiens 137-152 16104640-7 2005 CONCLUSION: Detection of free and CIC tuberculous serine protease antigen along with antibody is more useful for detecting TB in the presence of HIV co-infection. Terbium 123-125 coagulation factor II, thrombin Homo sapiens 50-65